763 related articles for article (PubMed ID: 15347376)
1. Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.
van Wijk F; Hartgring S; Koppelman SJ; Pieters R; Knippels LM
Clin Exp Allergy; 2004 Sep; 34(9):1422-8. PubMed ID: 15347376
[TBL] [Abstract][Full Text] [Related]
2. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
[TBL] [Abstract][Full Text] [Related]
3. The effect of the food matrix on in vivo immune responses to purified peanut allergens.
van Wijk F; Nierkens S; Hassing I; Feijen M; Koppelman SJ; de Jong GA; Pieters R; Knippels LM
Toxicol Sci; 2005 Aug; 86(2):333-41. PubMed ID: 15858220
[TBL] [Abstract][Full Text] [Related]
4. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization.
Strid J; Hourihane J; Kimber I; Callard R; Strobel S
Clin Exp Allergy; 2005 Jun; 35(6):757-66. PubMed ID: 15969667
[TBL] [Abstract][Full Text] [Related]
5. T cell responses to major peanut allergens in children with and without peanut allergy.
Flinterman AE; Pasmans SG; den Hartog Jager CF; Hoekstra MO; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Clin Exp Allergy; 2010 Apr; 40(4):590-7. PubMed ID: 20067479
[TBL] [Abstract][Full Text] [Related]
6. The importance of dietary control in the development of a peanut allergy model in Brown Norway rats.
de Jonge JD; Knippels LM; Ezendam J; Odink J; Penninks AH; van Loveren H
Methods; 2007 Jan; 41(1):99-111. PubMed ID: 17161306
[TBL] [Abstract][Full Text] [Related]
7. Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin.
Adel-Patient K; Bernard H; Ah-Leung S; Créminon C; Wal JM
Allergy; 2005 May; 60(5):658-64. PubMed ID: 15813812
[TBL] [Abstract][Full Text] [Related]
8. Clinical allergy to hazelnut and peanut: identification of T cell cross-reactive allergens.
Glaspole IN; de Leon MP; Prickett SR; O'Hehir RE; Rolland JM
Int Arch Allergy Immunol; 2011; 155(4):345-54. PubMed ID: 21346364
[TBL] [Abstract][Full Text] [Related]
9. Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population.
Krause S; Reese G; Randow S; Zennaro D; Quaratino D; Palazzo P; Ciardiello MA; Petersen A; Becker WM; Mari A
J Allergy Clin Immunol; 2009 Oct; 124(4):771-8.e5. PubMed ID: 19665774
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous or respiratory exposures to peanut allergens in mice and their impacts on subsequent oral exposure.
Wavrin S; Bernard H; Wal JM; Adel-Patient K
Int Arch Allergy Immunol; 2014; 164(3):189-99. PubMed ID: 25034179
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) CD25(+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy.
Marcondes Rezende M; Hassing I; Bol-Schoenmakers M; Bleumink R; Boon L; van Bilsen J; Pieters R
Clin Exp Allergy; 2011 Sep; 41(9):1324-33. PubMed ID: 21338425
[TBL] [Abstract][Full Text] [Related]
12. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.
Blanc F; Adel-Patient K; Drumare MF; Paty E; Wal JM; Bernard H
Clin Exp Allergy; 2009 Aug; 39(8):1277-85. PubMed ID: 19538351
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation.
McDermott RA; Porterfield HS; El Mezayen R; Burks AW; Pons L; Schlichting DG; Solomon B; Redzic JS; Harbeck RJ; Duncan MW; Hansen KC; Dreskin SC
Clin Exp Allergy; 2007 May; 37(5):752-63. PubMed ID: 17456223
[TBL] [Abstract][Full Text] [Related]
14. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2.
Glaspole IN; de Leon MP; Rolland JM; O'Hehir RE
Allergy; 2005 Jan; 60(1):35-40. PubMed ID: 15575928
[TBL] [Abstract][Full Text] [Related]
16. Influence of thermal processing on the allergenicity of peanut proteins.
Mondoulet L; Paty E; Drumare MF; Ah-Leung S; Scheinmann P; Willemot RM; Wal JM; Bernard H
J Agric Food Chem; 2005 Jun; 53(11):4547-53. PubMed ID: 15913323
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IgE antibodies to recombinant peanut allergens in patients with reported reactions to peanut.
Movérare R; Ahlstedt S; Bengtsson U; Borres MP; van Hage M; Poorafshar M; Sjölander S; Akerström J; van Odijk J
Int Arch Allergy Immunol; 2011; 156(3):282-90. PubMed ID: 21720173
[TBL] [Abstract][Full Text] [Related]
18. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen.
Koppelman SJ; Wensing M; Ertmann M; Knulst AC; Knol EF
Clin Exp Allergy; 2004 Apr; 34(4):583-90. PubMed ID: 15080811
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of allergenicity of genetically modified soybean protein extract in a murine model of oral allergen-specific sensitization.
Gizzarelli F; Corinti S; Barletta B; Iacovacci P; Brunetto B; Butteroni C; Afferni C; Onori R; Miraglia M; Panzini G; Di Felice G; Tinghino R
Clin Exp Allergy; 2006 Feb; 36(2):238-48. PubMed ID: 16433863
[TBL] [Abstract][Full Text] [Related]
20. IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens.
de Leon MP; Drew AC; Glaspole IN; Suphioglu C; O'Hehir RE; Rolland JM
Mol Immunol; 2007 Jan; 44(4):463-71. PubMed ID: 16580071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
